The purpose of this study is to determine the safety and efficacy of epinastine nasal spray compared to placebo for the treatment of subjects with seasonal allergic rhinitis

Inclusion Criteria:

• A documented history of seasonal allergic rhinitis to mountain cedar or other spring pollen

Exclusion Criteria:

• Significant medical condition
• Significant nasal abnormality
• Significant cardiac condition
• Recent infection
• Use of other allergy medication during the study
• Use of asthma medication other than as-needed albuterol

http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final\_Updated%20July\_9\_2014.pdf

http://engagezone.msd.com/ds\_documentation.php